Standardization and Clinical Utility of Thrombin-Generation Assays

 

 Buy Article Permissions and Reprints

ABSTRACT

Thrombin generation is a key process that determines the extent of a hemostatic plug or a thrombotic process. The ensuing thrombin burst is crucial for the formation of a stable fibrin clot. During its active life, thrombin exerts a multitude of highly regulated actions on the blood and the vessel wall, including the clotting of fibrinogen. The inappropriate generation of thrombin may lead to pathologic processes, foremost of which are hemorrhagic or thrombotic diseases. The coagulation system is usually investigated by means of two in vitro classic clotting tests, the activated partial thromboplastin time (APTT) and prothrombin time (PT), which assess only time to initiation of clot formation and do not entirely reflect global hemostatic balance. The APTT and PT permit identification of connectivity between the component activities identified as required for plasma coagulation and define the concept of intrinsic and extrinsic coagulation pathways, which converge at the point of formation of the prothrombinase complex. However, the mechanisms established by in vitro tests are not always mirrored in the human pathologies associated with bleeding or thrombosis. The recent development of newer tests based on the continuous registration of thrombin generation under in vitro conditions that mimic more closely what occurs in vivo prompt a reinvestigation of the balance between procoagulants and anticoagulants in patients with various hemostatic disorders. Thrombin-generation assays not only provide an overall assessment of hemostasis but also target potential extrahemostatic effects of the generated thrombin, a potent agonist of a multitude of cellular activation pathways. Moreover, estimation of an individual's thrombin-generation potential may correlate more closely with a hypercoagulable or hypocoagulable phenotype when compared with traditional coagulation tests. In this review, we discuss to what extent thrombin generation can be expected to reflect the clotting function of blood, the development and use of different thrombin-generation assay systems suitable for detecting changes in the kinetics of thrombin generation, and the clinical utility of thrombin generation.

REFERENCES

• 1 MacFarlane R G. An enzyme cascade in the blood clotting mechanism and its function as a biochemical amplifier.  Nature. 1964;  202 498-499
  CrossrefPubMedGoogle Scholar
• 2 Butenas S, van't Veer C, Mann K G. “Normal” thrombin generation.  Blood. 1999;  94 2169-2178
  PubMedGoogle Scholar
• 3 Dahlbäck B. Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases.  J Intern Med. 2005;  257 209-223
  CrossrefPubMedGoogle Scholar
• 4 Dargaud Y, Luddington R, Gray E et al.. Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study.  Br J Haematol. 2007;  139 303-309
  CrossrefPubMedGoogle Scholar
• 5 Lippi G, Franchini M, Guidi G C. Diagnostic approach to inherited bleeding disorders.  Clin Chem Lab Med. 2007;  45 2-12
  CrossrefPubMedGoogle Scholar
• 6 Mann K G, Brummel K, Butenas S. What is all that thrombin for?.  J Thromb Haemost. 2003;  1 1504-1514
  CrossrefPubMedGoogle Scholar
• 7 Tripodi A, Salerno F, Chantarangkul V et al.. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests.  Hepatology. 2005;  41 553-558
  CrossrefPubMedGoogle Scholar
• 8 Mann K G, Butenas S, Brummel K. The dynamics of thrombin formation.  Arterioscler Thromb Vasc Biol. 2003;  23 17-25
  CrossrefPubMedGoogle Scholar
• 9 Tripodi A, Martinelli I, Chantarangkul V et al.. The endogeneous thrombin potential and the risk of venous thromboembolism.  Thromb Res. 2007;  121 353-359
  CrossrefPubMedGoogle Scholar
• 10 Furie B, Furie B C. In vivo thrombus formation.  J Thromb Haemost. 2007;  5(Suppl 1) 12-17
  PubMedGoogle Scholar
• 11 Hartert H. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren.  Klin Wochenschr. 1948;  26 577-583
  CrossrefPubMedGoogle Scholar
• 12 Macfarlane R G, Biggs R. A thrombin generation test; the application in haemophilia and thrombocytopenia.  J Clin Pathol. 1953;  6 3-8
  CrossrefPubMedGoogle Scholar
• 13 Hemker H C, Willems G M, Beguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes.  Thromb Haemost. 1986;  56 9-17
  PubMedGoogle Scholar
• 14 Hemker H C, Beguin S. Thrombin generation in plasma: its assessment via the endogenous thrombin potential.  Thromb Haemost. 1995;  74 134-138
  PubMedGoogle Scholar
• 15 Pitney W R, Dacie J V. A simple method of studying the generation of thrombin in recalcified plasma; application in the investigation of haemophilia.  J Clin Pathol. 1953;  6 9-14
  CrossrefPubMedGoogle Scholar
• 16 Hemker H C, Wielders S, Kessels H, Béguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential.  Thromb Haemost. 1993;  70 617-624
  PubMedGoogle Scholar
• 17 Hemker H C, Giesen P L, Ramjee M, Wagenvoord R, Béguin S. The thrombogram: monitoring thrombin generation in platelet-rich plasma.  Thromb Haemost. 2000;  83 589-591
  PubMedGoogle Scholar
• 18 Hemker H C, Al Dieri R, De Smedt E, Béguin S. Thrombin generation, a function test of the haemostatic-thrombotic system.  Thromb Haemost. 2006;  96 553-561
  Article in Thieme ConnectPubMedGoogle Scholar
• 19 Hemker H C. Recollections on thrombin generation.  J Thromb Haemost. 2008;  6 219-226
  CrossrefPubMedGoogle Scholar
• 20 Váradi K, Negrier C, Berntorp E et al.. Monitoring the bioavailability of FEIBA with a thrombin generation assay.  J Thromb Haemost. 2003;  1 2374-2380
  CrossrefPubMedGoogle Scholar
• 21 Devreese K, Wijns W, Combes I, Van Kerckhoven S, Hoylaerts M F. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.  Thromb Haemost. 2007;  98 600-613
  PubMedGoogle Scholar
• 22 Butenas S, Branda R F, van't Veer C, Cawthern K M, Mann K G. Platelets and phospholipids in tissue factor-initiated thrombin generation.  Thromb Haemost. 2001;  86 660-667
  PubMedGoogle Scholar
• 23 Butenas S, Brummel K E, Paradis S G, Mann K G. Influence of factor VIIa and phospholipids on coagulation in “acquired” hemophilia.  Arterioscler Thromb Vasc Biol. 2003;  23 123-129
  CrossrefPubMedGoogle Scholar
• 24 van Veen J J, Gatt A, Bowyer A E, Cooper P C, Kitchen S, Makris M. The effect of tissue factor concentration on calibrated automated thrombography in the presence of inhibitor bypass agents. 2008 Jan 9 [Epub ahead of print]
  Google Scholar
• 25 Butenas S, Brummel K E, Branda R F, Paradis S G, Mann K G. Mechanism of factor VIIa-dependent coagulation in hemophilia blood.  Blood. 2002;  99 923-930
  CrossrefPubMedGoogle Scholar
• 26 Dielis A W, Castoldi E, Spronk H M et al.. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population.  J Thromb Haemost. 2008;  6 125-131
  PubMedGoogle Scholar
• 27 Siegemund A, Petros S, Siegemund T, Scholz U, Seyfarth H J, Engelmann L. The endogenous thrombin potential and high levels of coagulation factor VIII, factor IX and factor XI.  Blood Coagul Fibrinolysis. 2004;  15 241-244
  CrossrefPubMedGoogle Scholar
• 28 Gerotziafas G T, Depasse F, Busson J, Leflem L, Elalamy I, Samama M M. Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay.  Thromb J. 2005;  3 16
  CrossrefPubMedGoogle Scholar
• 29 Ignjatovic V, Greenway A, Summerhayes R, Monagle P. Thrombin generation: the functional role of alpha-2-macroglobulin and influence of developmental haemostasis.  Br J Haematol. 2007;  138 366-368
  CrossrefPubMedGoogle Scholar
• 30 Hemker H C, Al Dieri R, Béguin S. Thrombin generation assays: accruing clinical relevance.  Curr Opin Hematol. 2004;  11 170-175
  CrossrefPubMedGoogle Scholar
• 31 Hemker H C, de Smedt E, Al Dieri R. The contribution of alpha(2)-macroglobulin thrombin to the endogenous thrombin potential.  Br J Haematol. 2007;  139 513
  PubMedGoogle Scholar
• 32 Luddington R, Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition.  J Thromb Haemost. 2004;  2 1954-1959
  CrossrefPubMedGoogle Scholar
• 33 Silverberg M, Dunn J, Garen L, Kaplan A. Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate.  J Biol Chem. 1980;  255 7281-7286
  PubMedGoogle Scholar
• 34 Hong J, Larsson A, Ekdahl K, Elgue G, Larsson R, Nilsson B. Contact between a polymer and whole blood: sequence of events leading to thrombin generation.  J Lab Clin Med. 2001;  138 139-145
  CrossrefPubMedGoogle Scholar
• 35 Colman R W, Schmaier A H. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes.  Blood. 1997;  90 3819-3843
  PubMedGoogle Scholar
• 36 Rand M D, Lock J B, van't Veer C, Gaffney D P, Mann K G. Blood clotting in minimally altered whole blood.  Blood. 1996;  88 3432-3445
  PubMedGoogle Scholar
• 37 Bidot L, Jy W, Bidot Jr C et al.. Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis.  J Thromb Haemost. 2008;  6 913-919
  CrossrefPubMedGoogle Scholar
• 38 Pereira J, Alfaro G, Goycoolea M et al.. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.  Thromb Haemost. 2006;  95 94-99
  PubMedGoogle Scholar
• 39 Tappenden K A, Gallimore M J, Evans G, Mackie I J, Jones D W. Thrombin generation: a comparison of assays using platelet-poor and -rich plasma and whole blood samples from healthy controls and patients with a history of venous thromboembolism.  Br J Haematol. 2007;  139 106-112
  CrossrefPubMedGoogle Scholar
• 40 Keularts I M, Zivelin A, Seligsohn U, Hemker H C, Béguin S. The role of factor XI in thrombin generation induced by low concentrations of tissue factor.  Thromb Haemost. 2001;  85 1060-1065
  PubMedGoogle Scholar
• 41 Kyrle P A, Mannhalter C, Béguin S et al.. Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene.  Arterioscler Thromb Vasc Biol. 1998;  18 1287-1291
  PubMedGoogle Scholar
• 42 Regnault V, Béguin S, Wahl D et al.. Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants.  Thromb Haemost. 2003;  89 208-212
  PubMedGoogle Scholar
• 43 Gerotziafas G T, Chakroun T, Depasse F, Arzoglou P, Samama M M, Elalamy I. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.  Thromb Haemost. 2004;  91 977-985
  PubMedGoogle Scholar
• 44 Hemker H C, Giesen P, Al Dieri R et al.. Calibrated automated thrombin generation measurement in clotting plasma.  Pathophysiol Haemost Thromb. 2003;  33 4-15
  CrossrefPubMedGoogle Scholar
• 45 Hézard N, Remy M G, Florent B, Nguyen P. Reliability of thrombin generation assay on frozen-thawed platelet-rich plasma: a reply.  Clin Chem. 2006;  52 2127-2128
  CrossrefPubMedGoogle Scholar
• 46 Lippi G, Salvagno G L, Montagnana M, Guidi G C. Reliability of the thrombin-generation assay in frozen-thawed platelet-rich plasma.  Clin Chem. 2006;  52 1827-1828
  CrossrefPubMedGoogle Scholar
• 47 Chantarangkul V, Clerici M, Bressi C, Giesen P L, Tripodi A. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability.  Haematologica. 2003;  88 547-554
  PubMedGoogle Scholar
• 48 Holub B J, Philbrick D J, Parbtani A, Clark W F. Dietary lipid modification of renal disorders and ether phospholipid metabolism.  Biochem Cell Biol. 1991;  69 485-489
  PubMedGoogle Scholar
• 49 Baglin T. The measurement and application of thrombin generation.  Br J Haematol. 2005;  130 653-661
  CrossrefPubMedGoogle Scholar
• 50 Turecek P L, Váradi K, Keil B et al.. Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay.  Pathophysiol Haemost Thromb. 2003;  33 16-22
  CrossrefPubMedGoogle Scholar
• 51 Seré K M, Rosing J, Hackeng T M. Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance.  Blood. 2004;  104 3624-3630
  CrossrefPubMedGoogle Scholar
• 52 Hackeng T M, Seré K M, Tans G, Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.  Proc Natl Acad Sci U S A. 2006;  103 3106-3111
  CrossrefPubMedGoogle Scholar
• 53 Dargaud Y, Lienhart A, Meunier S et al.. Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision.  Haemophilia. 2005;  11 552-558
  CrossrefPubMedGoogle Scholar
• 54 Salvagno G L, Astermark J, Ekman M et al.. Impact of different inhibitor reactivities with commercial factor VIII concentrates on thrombin generation.  Haemophilia. 2007;  13 51-56
  CrossrefPubMedGoogle Scholar
• 55 Berntorp E. VWF/FVIII complex and the management of patient with inhibitors: from laboratory to clinical practice.  Haemophilia. 2007;  13(Suppl 5) 69-72
  CrossrefPubMedGoogle Scholar
• 56 Váradi K, Turecek P L, Schwarz H P. Thrombin generation assay and other universal tests for monitoring haemophilia therapy.  Haemophilia. 2004;  10 17-21
  PubMedGoogle Scholar
• 57 Livnat T, Martinowitz U, Zivelin A, Seligsohn U. Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma.  Haemophilia. 2008;  , Mar 25 [Epub ahead of print]
  PubMedGoogle Scholar
• 58 Lewis S J, Stephens E, Florou G et al.. Measurement of global haemostasis in severe haemophilia A following factor VIII infusion.  Br J Haematol. 2007;  138 775-782
  CrossrefPubMedGoogle Scholar
• 59 Matsumoto T, Shima M, Takeyama M et al.. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay.  J Thromb Haemost. 2006;  4 377-384
  CrossrefPubMedGoogle Scholar
• 60 Beltrán-Miranda C P, Khan A, Jaloma-Cruz A R, Laffan M A. Thrombin generation and phenotypic correlation in haemophilia A.  Haemophilia. 2005;  11 326-334
  CrossrefPubMedGoogle Scholar
• 61 Mitka M. Guidelines for von Willebrand disease urge routine screening for bleeding.  JAMA. 2008;  299 1890
  CrossrefPubMedGoogle Scholar
• 62 Rugeri L, Beguin S, Hemker C et al.. Thrombin-generating capacity in patients with von Willebrand's disease.  Haematologica. 2007;  92 1639-1646
  CrossrefPubMedGoogle Scholar
• 63 Quiroga T, Goycoolea M, Giesen P L et al.. Thrombin generation in platelet-poor plasma is normal in patients with hereditary mucocutaneous haemorrhages.  Pathophysiol Haemost Thromb. 2003;  33 30-35
  CrossrefPubMedGoogle Scholar
• 64 Keularts I M, Hamulyak K, Hemker H C, Béguin S. The effect of DDAVP infusion on thrombin generation in platelet-rich plasma of von Willebrand type 1 and in mild haemophilia A patients.  Thromb Haemost. 2000;  84 638-642
  PubMedGoogle Scholar
• 65 Al Dieri R, Peyvandi F, Santagostino E et al.. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding.  Thromb Haemost. 2002;  88 576-582
  PubMedGoogle Scholar
• 66 Béguin S, Keularts I, Al Dieri R, Bellucci S, Caen J, Hemker H C. Fibrin polymerization is crucial for thrombin generation in platelet-rich plasma in a VWF-GPIb-dependent process, defective in Bernard-Soulier syndrome.  J Thromb Haemost. 2004;  2 170-176
  CrossrefPubMedGoogle Scholar
• 67 Reverter J C, Béguin S, Kessels H, Kumar R, Hemker H C, Coller B S. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and “clinical restenosis”.  J Clin Invest. 1996;  98 863-874
  CrossrefPubMedGoogle Scholar
• 68 Tripodi A, Mannucci P M. Laboratory investigation of thrombophilia.  Clin Chem. 2001;  47 1597-1606
  PubMedGoogle Scholar
• 69 Couturaud F, Duchemin J, Leroyer C, Delahousse B, Abgrall J F, Mottier D. Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O). Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.  Thromb Haemost. 2008;  99 223-228
  PubMedGoogle Scholar
• 70 Hézard N, Bouaziz-Borgi L, Remy M G, Nguyen P. Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and prothrombin G20210A mutations and protein S deficiency.  Clin Chem. 2006;  52 665-670
  CrossrefPubMedGoogle Scholar
• 71 Hron G, Kollars M, Binder B R, Eichinger S, Kyrle P A. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation.  JAMA. 2006;  296 397-402
  CrossrefPubMedGoogle Scholar
• 72 Simioni P, Tormene D, Spiezia L et al.. Inherited thrombophilia and venous thromboembolism.  Semin Thromb Hemost. 2006;  32 700-708
  Article in Thieme ConnectPubMedGoogle Scholar
• 73 van Hylckama Vlieg A, Christiansen S C, Luddington R et al.. Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence.  Br J Haematol. 2007;  138 769-774
  CrossrefPubMedGoogle Scholar
• 74 Hankey G J. Stroke: how large a public health problem, and how can the neurologist help?.  Arch Neurol. 1999;  56 748-754
  CrossrefPubMedGoogle Scholar
• 75 Anzej S, Bozic M, Antovic A et al.. Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia.  Thromb Res. 2007;  120 39-46
  CrossrefPubMedGoogle Scholar
• 76 Faber C G, Lodder J, Kessels F, Troost J. Thrombin generation in platelet-rich plasma as a tool for the detection of hypercoagulability in young stroke patients.  Pathophysiol Haemost Thromb. 2003;  33 52-58
  CrossrefPubMedGoogle Scholar
• 77 Brummel-Ziedins K, Undas A, Orfeo T et al.. Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition.  J Thromb Haemost. 2008;  6 104-110
  PubMedGoogle Scholar
• 78 Orbe J, Zudaire M, Serrano R et al.. Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test.  Thromb Haemost. 2008;  99 382-387
  PubMedGoogle Scholar
• 79 Franchini M. Haemostasis and pregnancy.  Thromb Haemost. 2006;  95 401-413
  PubMedGoogle Scholar
• 80 Dati F, Pelzer H, Wagner C. Relevance of markers of hemostasis activation in obstetrics/gynecology and pediatrics.  Semin Thromb Hemost. 1998;  24 443-448
  Article in Thieme ConnectPubMedGoogle Scholar
• 81 Perry Jr K G, Martin Jr J N. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia.  Clin Obstet Gynecol. 1992;  35 338-350
  PubMedGoogle Scholar
• 82 Bremme K, Blombäck M. Hemostatic abnormalities may predict chronic hypertension after preeclampsia.  Gynecol Obstet Invest. 1996;  41 20-26
  CrossrefPubMedGoogle Scholar
• 83 Spaanderman M E, Van Beek E, Ekhart T H et al.. Changes in hemodynamic parameters and volume homeostasis with the menstrual cycle among women with a history of preeclampsia.  Am J Obstet Gynecol. 2000;  182 1127-1134
  CrossrefPubMedGoogle Scholar
• 84 Rafik Hamad R, Curvers J, Berntorp E, Eriksson M, Bremme K.. Increased thrombin generation in women with a history of preeclampsia.  Thromb Res. 2008;  , May 21 [Epub ahead of print]
  PubMedGoogle Scholar
• 85 Tripodi A, Salerno F, Chantarangkul V et al.. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests.  Hepatology. 2005;  41 553-558
  CrossrefPubMedGoogle Scholar
• 86 Tripodi A, Primignani M, Chantarangkul V et al.. Thrombin generation in patients with cirrhosis: the role of platelets.  Hepatology. 2006;  44 440-445
  CrossrefPubMedGoogle Scholar
• 87 Tripodi A, Ramenghi L A, Chantarangkul V et al.. Normal thrombin generation in neonates in spite of prolonged conventional coagulation tests.  Haematologica. 2008;  93 1256-1259
  CrossrefPubMedGoogle Scholar
• 88 van Veen J J, Gatt A, Makris M. Thrombin generation testing in routine clinical practice: are we there yet?.  Br J Haematol. 2008;  142 889-903
  CrossrefPubMedGoogle Scholar
• 89 Shima M, Matsumoto T, Ogiwara K. New assays for monitoring haemophilia treatment.  Haemophilia. 2008;  14(Suppl 3) 83-92
  CrossrefPubMedGoogle Scholar

Gian Luca SalvagnoM.D. 

Sezione di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche

Università degli Studi di Verona, Ospedale Policlinico G.B. Rossi, Piazzale Scuro, 10, 37134 – Verona, Italy

Email: gsalvagno77@yahoo.it

Email: gianluca.salvagno@univr.it